- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 13th, 2005
Dr. James Baker, biologic nanotechnology professor at the University of Michigan, wrote yesterday:
Nanotechnology is a very young science and most of the breakthrough advances are in early stage development. Because it takes up to eight to ten years to get approval for new therapeutics, there will be a significant delay with many of the more remarkable applications for nanotechnology. Thus, the five-year window is less likely to bring unique change, whereas the ten to twenty year window is probably when the more remarkable applications will be seen.
My only question -- and it's probably a naive one, but it takes a simple man to ask a simple question -- is "why?"
Howard Lovy's NanoBot
|Related News Press|
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016
Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016